Glibornuride: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 1: Line 1:
<!--Drug box 2-->
{{chembox
[[File:Glibornuride.png|thumb|none|400px|This image is provided by the National Library of Medicine.]]
| Verifiedfields = changed
__NOTOC__
| UNII_Ref = {{fdacite|correct|FDA}}
{{SI}}
| UNII = VP83E7434R
{{CMG}}
| verifiedrevid = 444003955
|ImageFile=Glibornuride02.png
 
|ImageSize=200px
|IUPACName=1-(6-hydroxy-1,7,7-trimethyl-5-bicyclo[2.2.1]heptanyl)-3-(4-methylphenyl)sulfonylurea
|OtherNames=
|Section1={{Chembox Identifiers
| CASNo_Ref = {{cascite|correct|??}}
| CASNo=26944-48-9
| PubChem=33649
| DrugBank_Ref = {{drugbankcite|changed|drugbank}}
| DrugBank = DB08962
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D02427
| SMILES=CC1=CC=C(C=C1)S(=O)(=O)NC(=O)NC2C3CCC(C2O)(C3(C)C)C
| ATCCode_prefix = A10
| ATCCode_suffix = BB04
  }}
|Section2={{Chembox Properties
|  Formula=C<sub>18</sub>H<sub>26</sub>N<sub>2</sub>O<sub>4</sub>S
|  MolarMass=366.48 g/mol
| Appearance=
| Density=
| MeltingPt=
| BoilingPt=
|  Solubility=
  }}
|Section3={{Chembox Hazards
|  MainHazards=
|  FlashPt=
|  Autoignition=
  }}
}}


==Overview==
==Overview==

Revision as of 20:54, 6 April 2015

Template:Chembox E number
Glibornuride
Names
IUPAC name
1-(6-hydroxy-1,7,7-trimethyl-5-bicyclo[2.2.1]heptanyl)-3-(4-methylphenyl)sulfonylurea
Identifiers
3D model (JSmol)
DrugBank
ECHA InfoCard Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value). Lua error in Module:Wikidata at line 879: attempt to index field 'wikibase' (a nil value).
KEGG
Properties
C18H26N2O4S
Molar mass 366.48 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is ☑Y☒N ?)
Infobox references

Overview

Glibornuride (INN) is an anti-diabetic drug from the group of sulfonylureas.[1]

References

  1. Haupt E, Köberich W, Beyer J, Schöffling K (December 1971). "Pharmacodynamic aspects of tolbutamide, glibenclamide, glibornuride and glisoxepide. I. Dose response relations and repeated administration in diabetic subjects". Diabetologia. 7 (6): 449–54. doi:10.1007/bf01212061. PMID 5004178.